| CIMCX | RMATX | CIMCX / RMATX | |
| Total Expense Ratio | 1.35 | 0.79 | 171% |
| Annual Report Gross Expense Ratio | 1.35 | 1.07 | 126% |
| Fund Existence | 24 years | 9 years | - |
| Gain YTD | 13.465 | 14.938 | 90% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 138B | 579M | 23,834% |
| Annual Yield % from dividends | 2.85 | 3.46 | 82% |
| Returns for 1 year | 9.03 | 13.74 | 66% |
| Returns for 3 years | 26.43 | 43.52 | 61% |
| Returns for 5 years | 34.76 | 28.68 | 121% |
| Returns for 10 years | 65.79 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| XSVM | 53.58 | 0.40 | +0.75% |
| Invesco S&P SmallCap Value with Momt ETF | |||
| KSEP | 26.98 | 0.11 | +0.39% |
| Innovator U.S. Small Cp Pwr Buf ETF -Sep | |||
| CGCP | 22.66 | 0.03 | +0.13% |
| Capital Group Core Plus Income ETF | |||
| HELX | 34.99 | N/A | N/A |
| Franklin Genomic Advancements ETF | |||
| PHEQ | 32.00 | -0.07 | -0.20% |
| Parametric Hedged Equity ETF | |||